Nalaganje...
Next generation therapeutics for inflammatory bowel disease
Tumor necrosis factor (TNF)-antagonists are the cornerstone of therapy for moderately-severely active inflammatory bowel disease (IBD). Although our understanding of pharmacokinetics, pharmacodynamics, and treatment optimization for these agents has evolved considerably over the past decade, a subst...
Shranjeno v:
| izdano v: | Curr Gastroenterol Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5901649/ https://ncbi.nlm.nih.gov/pubmed/27461274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11894-016-0522-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|